Denosumab for prevention of fractures in men receiving androgen deprivation therapy (ADT) for prostate cancer (PC)

被引：0
|
作者：
Saad, F.
Smith, M. R.
Egerdie, B.
Tammela, T. L.
Feldman, R. A.
Heracek, J.
Szwedowski, M.
Ke, C.
Leder, B.
Goessl, C.
机构：
[1] Univ Montreal, Ctr Hosp, Montreal, PQ, Canada
[2] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA
[3] Urol Associates, Urol Med Res, Kitchener, ON, Canada
[4] Tampere Univ Hosp, Tampere, Finland
[5] Connecticut Clin Res Ctr, Urol Specialists, Middlebury, CT USA
[6] Androgeos, Prague, Czech Republic
[7] Wojewodzkie Ctr Medyczne, Opole, Poland
[8] Amgen Inc, Thousand Oaks, CA 91320 USA
[9] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5056
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Does Use of Androgen Deprivation Therapy (ADT) in Men with Prostate Cancer Increase the Risk of Sarcopenia?
    Owen, Patrick J.
    Daly, Robin M.
    Dalla Via, Jack
    Mundell, Niamh L.
    Livingston, Patricia M.
    Rantalainen, Timo
    Fraser, Steve F.
    CALCIFIED TISSUE INTERNATIONAL, 2019, 105 (04) : 403 - 411
  • [32] A Review on the Effects of Androgen Deprivation Therapy (ADT) on Bone Health Status in Men with Prostate Cancer
    Mohamad, Nur-Vaizura
    Soelaiman, Ima-Nirwana
    Chin, Kok-Yong
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2017, 17 (04) : 276 - 284
  • [33] Does Use of Androgen Deprivation Therapy (ADT) in Men with Prostate Cancer Increase the Risk of Sarcopenia?
    Patrick J. Owen
    Robin M. Daly
    Jack Dalla Via
    Niamh L. Mundell
    Patricia M. Livingston
    Timo Rantalainen
    Steve F. Fraser
    Calcified Tissue International, 2019, 105 : 403 - 411
  • [34] The Use of Androgen Deprivation Therapy (ADT) and Chemotherapeutic Agents in New Zealand Men with Prostate Cancer
    Lawrenson, Ross
    Obertova, Zuzana
    Brown, Charis
    Fong, Peter
    Tyrie, Leanne
    Scott, Nina
    Holmes, Michael
    JOURNAL OF CANCER, 2014, 5 (03): : 214 - 220
  • [35] A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy
    C Ellen Lee
    William D Leslie
    YK James Lau
    BMC Cancer, 12
  • [36] Bisphosphonates to prevent osteoporosis in men receiving androgen deprivation therapy for prostate cancer
    Smith, MR
    DRUGS & AGING, 2003, 20 (03) : 175 - 183
  • [37] PREVALENCE OF MAJOR ADVERSE CARDIAC EVENTS (MACE) IN PATIENTS WITH PROSTATE CANCER (PC) RECEIVING ANDROGEN DEPRIVATION THERAPY (ADT) IN THE UNITED STATES
    Brady, B.
    Pruett, J.
    Winer, I
    van Veenhuyzen, D.
    Dufour, R.
    VALUE IN HEALTH, 2020, 23 : S457 - S457
  • [38] MAJOR ADVERSE CARDIOVASCULAR EVENT HOSPITALIZATION BURDEN IN PATIENTS WITH PROSTATE CANCER (PC) RECEIVING ANDROGEN DEPRIVATION THERAPY (ADT) IN THE UNITED STATES
    Brady, B.
    Pruett, J.
    Winer, I
    van Veenhuyzen, D.
    Hunsche, E.
    Dufour, R.
    VALUE IN HEALTH, 2020, 23 : S449 - S450
  • [39] A pilot study of exercise in men with prostate cancer receiving androgen deprivation therapy
    Lee, C. Ellen
    Leslie, William D.
    Lau, Y. K. James
    BMC CANCER, 2012, 12
  • [40] Managing hot flushes in men receiving androgen deprivation therapy for prostate cancer
    Khan, Atia
    Lewis, Rachel
    Hughes, Simon
    TRENDS IN UROLOGY & MENS HEALTH, 2014, 5 (01) : 31 - 33
12345